Could a common arthritis drug prevent preterm birth?

NCT ID NCT05703425

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether sulfasalazine, a drug used for arthritis, can lower a stress hormone called CRH and prevent recurrent preterm birth. Fifty pregnant women with a history of preterm birth will receive either sulfasalazine or no drug between 24 and 36 weeks of pregnancy. Researchers will track CRH levels and how many deliver early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

sulfasalazine

What this could lead to

If it works, this could offer a new way to prevent preterm birth in women who have had one before.

What could go wrong

This is a small, early-phase trial with only 50 participants, so results may not apply to everyone. The drug may not lower CRH levels or reduce preterm birth rates.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRETERM BIRTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rutgers Robert Wood Johnson Medical School

    RECRUITING

    New Brunswick, New Jersey, 08901, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••